Page last updated: 2024-11-04

sodium fluoride and Cancer of Pituitary

sodium fluoride has been researched along with Cancer of Pituitary in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19905 (71.43)18.7374
1990's2 (28.57)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gershengorn, MC1
Spada, A2
Nicosia, S1
Cortelazzi, L1
Pezzo, G1
Bassetti, M2
Sartorio, A1
Giannattasio, G1
Vertongen, P1
Delhase, M1
Rajas, F1
Trouillas, J1
Hooghe-Peters, E1
Svoboda, M1
Robberecht, P1
Arosio, M1
Bochicchio, D1
Bazzoni, N1
Vallar, L1
Faglia, G1
Summers, ST1
Cronin, MJ1
Reker, CE1
LaPointe, MC1
Kovacic-Milivojević, B1
Chiou, WJ1
Vedeckis, WV1
Svec, F1

Reviews

1 review available for sodium fluoride and Cancer of Pituitary

ArticleYear
Thyrotropin releasing hormone. A review of the mechanisms of acute stimulation of pituitary hormone release.
    Molecular and cellular biochemistry, 1982, Jun-25, Volume: 45, Issue:3

    Topics: 1-Methyl-3-isobutylxanthine; Animals; Calcium; Cells, Cultured; Chlortetracycline; Cyclic AMP; Guany

1982

Other Studies

6 other studies available for sodium fluoride and Cancer of Pituitary

ArticleYear
In vitro studies on prolactin release and adenylate cyclase activity in human prolactin-secreting pituitary adenomas. Different sensitivity of macro- and microadenomas to dopamine and vasoactive intestinal polypeptide.
    The Journal of clinical endocrinology and metabolism, 1983, Volume: 56, Issue:1

    Topics: Adenoma; Adenylyl Cyclases; Bucladesine; Culture Techniques; Dopamine; Dose-Response Relationship, D

1983
Pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptor subtypes are differently expressed in rat transplanted pituitary tumours (SMtTW) and in the normal gland.
    Journal of molecular endocrinology, 1996, Volume: 16, Issue:3

    Topics: Adenylyl Cyclases; Animals; Cell Line; Cell Membrane; Colforsin; DNA Primers; Guanosine Triphosphate

1996
Clinical, biochemical, and morphological correlates in patients bearing growth hormone-secreting pituitary tumors with or without constitutively active adenylyl cyclase.
    The Journal of clinical endocrinology and metabolism, 1990, Volume: 71, Issue:6

    Topics: Acromegaly; Adenoma; Adenylyl Cyclases; Adolescent; Adult; Aged; Cytoplasmic Granules; Dopamine; End

1990
Phorbol esters induce two distinct changes in GH3 pituitary cell adenylate cyclase activity.
    Archives of biochemistry and biophysics, 1988, Volume: 262, Issue:1

    Topics: Adenylyl Cyclases; Animals; Colforsin; Cyclic AMP; Enzyme Activation; Guanylyl Imidodiphosphate; Man

1988
A possible role for dephosphorylation in glucocorticoid receptor transformation.
    Journal of steroid biochemistry, 1987, Volume: 26, Issue:6

    Topics: Alkaline Phosphatase; Animals; Cell Line; Cytosol; Dexamethasone; Edetic Acid; Leupeptins; Mice; Pho

1987
Relationship between intact cell ATP levels and glucocorticoid receptor-binding capacity in the AtT-20 cell.
    Biochimica et biophysica acta, 1985, Oct-30, Volume: 847, Issue:1

    Topics: 2,4-Dinitrophenol; Adenosine Triphosphate; Animals; Cell Line; Dexamethasone; Dinitrophenols; Kineti

1985